What is alpha‑lipoic acid (ALA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Alpha-Lipoic Acid?

Alpha-lipoic acid (ALA) is a naturally occurring antioxidant and mitochondrial cofactor—specifically a medium-chain fatty acid derived from linoleic acid—that functions both as an endogenously synthesized compound in human tissues and as a therapeutic agent available in oral and intravenous formulations. 1

Chemical and Biological Properties

ALA is a sulfur-containing organic compound derived from octanoic acid that serves as an essential cofactor for mitochondrial respiratory enzymes 2, 3. What makes ALA unique among antioxidants is its dual nature: it exists in both an oxidized form (ALA) and a reduced form (dihydrolipoic acid, DHLA), with both forms exhibiting potent antioxidant activity 2, 4.

The ALA/DHLA system is amphiphilic—meaning it is soluble in both water and fat—allowing it to function throughout all cellular compartments, unlike most antioxidants that are limited to either aqueous or lipid environments 2, 4. This property has earned ALA the designation as the "antioxidant of antioxidants" because it not only directly scavenges reactive oxygen species but also regenerates other antioxidants including vitamins C and E and glutathione 2.

Distinction from Alpha-Linolenic Acid

It is critical to note that alpha-lipoic acid (ALA) is completely different from alpha-linolenic acid (also abbreviated ALA), which is an omega-3 essential fatty acid found in plant sources like flaxseed, walnuts, and certain vegetable oils 5, 6, 7. The context of your question and the evidence provided indicates you are asking about alpha-lipoic acid (the antioxidant), not alpha-linolenic acid (the omega-3 fatty acid). These are entirely distinct compounds with different chemical structures, biological functions, and clinical applications.

Clinical Applications

Diabetic Neuropathy

The most robust clinical evidence supports ALA use for diabetic peripheral neuropathy, where 27 randomized controlled trials have demonstrated benefit 1. A meta-analysis confirmed that oral ALA dosing of 600 mg once daily is equivalent to intravenous infusions for reducing neuropathic pain 1. The evidence supports intravenous administration of 600 mg per day over a 3-week period for clinically meaningful improvement in positive neuropathic symptoms and deficits 8.

Chemotherapy-Induced Neuropathy

For prevention of chemotherapy-induced peripheral neuropathy (CIPN), ALA is NOT recommended 9. A randomized, double-blind trial evaluating 600 mg ALA three times daily for 24 weeks in patients receiving platinum-based chemotherapy showed no ameliorating effect, with only 29% of patients completing the trial due to poor tolerability from the three-times-daily dosing requirement 9.

Other Potential Applications

Research evidence suggests ALA may have beneficial effects in:

  • Metabolic disorders and cardiovascular disease risk factors through blood lipid modulation and LDL oxidation protection 2, 10, 4
  • Neurodegenerative conditions including Alzheimer's and Parkinson's diseases through mitochondrial function improvement 2, 10, 3, 11
  • Kidney diseases through antioxidant and protective mechanisms 12
  • Metal toxicity mitigation (aluminum, arsenic, lead, mercury, cadmium) through chelation and antioxidant properties 13

Safety Considerations

ALA has a relatively narrow therapeutic index compared to other vitamin supplements, and overdose can cause severe, life-threatening toxicity 14. Clinical studies have shown safety and tolerability at doses around 600 mg daily, but accidental ingestion of 6 grams has resulted in rapid onset of confusion, seizures, lactic acidosis, and respiratory failure requiring intubation 14. The clinical picture of ALA toxicity includes gastrointestinal symptoms, altered mental status, seizure activity unresponsive to standard anticonvulsants, and circulatory instability 14. No antidote exists; management is purely supportive 14.

Formulations and Dosing

Standard therapeutic dosing is 600 mg once daily, administered either orally or intravenously 1, 8. Injectable formulations demonstrate superior bioavailability in experimental settings, though most clinical use involves oral administration 10. The compound is available as a dietary supplement, though the FDA drug label evidence provided 15 appears to reference a homeopathic preparation rather than standard pharmaceutical ALA formulations.

Mechanism of Action

ALA combats oxidative stress through multiple mechanisms: direct quenching of reactive oxygen species, metal chelation, regeneration of other antioxidants, modulation of inflammatory pathways, and enhancement of mitochondrial respiratory enzyme function 2, 10, 12, 4. Its endogenous synthesis occurs in mitochondria via lipoic acid synthase, but production decreases with age, potentially contributing to age-related disorders 12, 11.

References

Research

Alpha-Lipoic Acid: Biological Mechanisms and Health Benefits.

Antioxidants (Basel, Switzerland), 2024

Research

Alpha-lipoic acid and cardiovascular disease.

The Journal of nutrition, 2003

Research

Therapeutic applications of alpha-lipoic acid: A review of clinical and preclinical evidence (1998-2024).

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025

Research

Alpha-lipoic acid: A promising pharmacotherapy seen through the lens of kidney diseases.

Current research in pharmacology and drug discovery, 2024

Research

Alpha-lipoic acid, as an effective agent against toxic elements: a review.

Naunyn-Schmiedeberg's archives of pharmacology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.